Clinical Trial Update: Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adebrelimab in combination with chemotherapy, bevacizumab, and fluzoparib for platinum-sensitive relapsed ovarian cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Platinum-sensitive Relapsed Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING